Helius Medical expands reach of PoNS Therapy with Lovel Government Services

Helius Medical Technologies announced it has partnered with Lovell Government Services or Lovel, an SBA-certified Service Disabled Veteran Owned Small Business, SDVOSB, to make the Company’s Portable Neuromodulation Stimulator or PoNS device available to federal healthcare systems. PoNS is indicated in the U.S. for use as a short-term treatment of gait deficit in adults with mild-to-moderate symptoms from MS when used in conjunction with physical therapy. “Through their Multiple Sclerosis Centers of Excellence, the VA is dedicated to maximizing the quality of life for veterans suffering from MS, and we are thrilled to partner with Lovell to expand the reach of our innovative PoNS device. In a study of real-world results, after 14 weeks of PoNS Therapy, 100% of MS patients experienced a clinically meaningful improvement in gait. More than 28,000 cases of MS are reported to the VA annually, making PoNS a potential game changer for veterans and their families,” said Dane Andreeff, President and Chief Executive Officer of Helius.